OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Haematology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine	119
B‐cell lymphoma mimicking relapsing polychondritis	103
Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses	99
Cell erythroid maturation approach: a new paradigm in the road map towards a cure for β‐thalassaemia syndromes	93
Challenges and solutions to superior chimeric antigen receptor‐T design and deployment for B‐cell lymphomas	89
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant	81
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis	75
Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia	74
Exome sequencing in high and low fetal haemoglobin Arab–Indian haplotype sickle cell disease	65
What complements complement in transplant‐associated thrombotic microangiopathy?	62
Safety and efficacy of a Hb‐triggered single‐unit red cell transfusion policy for haemato‐oncological inpatients	60
	59
Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline	57
Whole‐blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise	57
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic targ	56
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis	55
MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report	53
Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation	52
Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients	52
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network	50
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study	49
Issue Information	49
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib	46
Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update	45
Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study	44

Prevalence of kidney health genetic variants in adults with sickle cell nephropathy	44
Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry	44
Delta‐globin gene expression improves sickle cell disease in a humanised mouse model	44
Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait	43
The 12‐week kinetics of anti‐SARS‐CoV‐2 antibodies in different haematological cancers after vaccination with BNT162b2	41
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry	41
Low levels of minimal residual disease after induction chemotherapy for BCR‐ABL1‐negative acute lymphoblastic leukaemia in adults are clinically relevant	40
Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective	39
Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post‐transplant setting	39
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis	38
Van der WaltJ., OraziA., ArberD. A. (editors) Diagnostic Bone Marrow HaematopathologyCambridge, UK: Cambridge University Press, 2021. ISBN 978‐1‐107‐14 500‐9.	38
Transient increase in platelet counts associated with COVID‐19 infection during TPO‐RA as the second‐line treatment in children with ITP	38
Issue Information	37
Adjunctive viral cell culture supports treatment decision‐making in patients with secondary humoral immunodeficiency and persistent SARS‐CoV‐2 infection	37